Revenue $1.95B, down 29.3% on a year earlier. Diluted EPS $0.20 against $2.38.
| Q2 FY26 | Q1 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $1.95B | $2.74B | $2.76B | -29.3% |
| Operating income | $158.00M | $273.00M | $198.00M | -20.2% |
| Net income | $50.00M | $169.00M | $612.00M | -91.8% |
| Diluted EPS | $0.20 | $0.66 | $2.38 | |
| Operating cash flow | $422.00M | $257.00M | $241.00M | +75.1% |
| Capital expenditures | -$136.00M | -$165.00M | -$95.00M | |
| Free cash flow | $286.00M | $92.00M | $146.00M | +95.9% |
| Dividend per share | $0.40 | $0.40 | $0.40 |
| Q2 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|
| Currency neutral sales growth | 6% | 3% | |
| Comparable Currency Neutral Sales Growth | 6% | 3% | |
| Taste Segment Sales | $688.00M | $631.00M | +9.0% |
| Scent segment sales | $665.00M | $603.00M | +10.3% |
| Health & Biosciences segment sales | $601.00M | $577.00M | +4.2% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “International Flavors & Fragrances (IFF) Q2 FY26 earnings: results and KPIs”, stockatlas.com/companies/IFF/earnings/2026-q2/, data as of 3 November 2026. Links to this page are welcome.
